 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0000064	L-ornithine transmembrane transporter activity	1	1.637095e-4	6.037606e-1	6.037606e-1	6.108382e+3	1.637095e-4	1	1.637095e-4	1.000000e+0	1	1.662879e-4	6.132698e-1	6.132698e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SLC25A15
GO Molecular Function	GO:0015179	L-amino acid transmembrane transporter activity	2	4.145031e-3	1.000000e+0	1.000000e+0	2.412527e+2	4.145031e-3	1	4.145031e-3	1.000000e+0	2	2.217172e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SLC25A15
GO Molecular Function	GO:0015171	amino acid transmembrane transporter activity	3	6.194287e-3	1.000000e+0	1.000000e+0	1.614391e+2	6.194287e-3	1	6.194287e-3	1.000000e+0	3	3.492046e-3	1.000000e+0	1.000000e+0	2.863651e+2	3.492046e-3	1	63	1.000000e+0	1.587302e-2	unnamed	SLC25A15
GO Molecular Function	GO:0046943	carboxylic acid transmembrane transporter activity	4	9.273213e-3	1.000000e+0	1.000000e+0	1.078375e+2	9.273213e-3	1	9.273213e-3	1.000000e+0	4	5.376642e-3	1.000000e+0	1.000000e+0	1.859897e+2	5.376642e-3	1	97	1.000000e+0	1.030928e-2	unnamed	SLC25A15
GO Molecular Function	GO:0005342	organic acid transmembrane transporter activity	5	9.533383e-3	1.000000e+0	1.000000e+0	1.048946e+2	9.533383e-3	1	9.533383e-3	1.000000e+0	5	5.542930e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	100	1.000000e+0	1.000000e-2	unnamed	SLC25A15
GO Molecular Function	GO:0008514	organic anion transmembrane transporter activity	6	1.165527e-2	1.000000e+0	1.000000e+0	8.579812e+1	1.165527e-2	1	1.165527e-2	1.000000e+0	6	7.261238e-3	1.000000e+0	1.000000e+0	1.377176e+2	7.261238e-3	1	131	1.000000e+0	7.633588e-3	unnamed	SLC25A15
GO Molecular Function	GO:0008509	anion transmembrane transporter activity	7	2.081351e-2	1.000000e+0	1.000000e+0	4.804572e+1	2.081351e-2	1	2.081351e-2	1.000000e+0	7	1.302589e-2	1.000000e+0	1.000000e+0	7.677021e+1	1.302589e-2	1	235	1.000000e+0	4.255319e-3	unnamed	SLC25A15
GO Molecular Function	GO:0008324	cation transmembrane transporter activity	8	6.410546e-2	1.000000e+0	1.000000e+0	1.559929e+1	6.410546e-2	1	6.410546e-2	1.000000e+0	8	3.270329e-2	1.000000e+0	1.000000e+0	3.057797e+1	3.270329e-2	1	590	1.000000e+0	1.694915e-3	unnamed	SLC25A15
GO Molecular Function	GO:0015075	ion transmembrane transporter activity	9	8.122600e-2	1.000000e+0	1.000000e+0	1.231133e+1	8.122600e-2	1	8.122600e-2	1.000000e+0	9	4.240341e-2	1.000000e+0	1.000000e+0	2.358301e+1	4.240341e-2	1	765	1.000000e+0	1.307190e-3	unnamed	SLC25A15
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	10	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	10	4.567374e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	824	1.000000e+0	1.213592e-3	unnamed	SLC25A15
GO Molecular Function	GO:0022857	transmembrane transporter activity	11	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	11	5.027438e-2	1.000000e+0	1.000000e+0	1.989085e+1	5.027438e-2	1	907	1.000000e+0	1.102536e-3	unnamed	SLC25A15
GO Molecular Function	GO:0022892	substrate-specific transporter activity	12	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	12	5.293498e-2	1.000000e+0	1.000000e+0	1.889110e+1	5.293498e-2	1	955	1.000000e+0	1.047120e-3	unnamed	SLC25A15
GO Molecular Function	GO:0005215	transporter activity	13	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	13	6.562829e-2	1.000000e+0	1.000000e+0	1.523733e+1	6.562829e-2	1	1184	1.000000e+0	8.445946e-4	unnamed	SLC25A15
GO Biological Process	GO:0000066	mitochondrial ornithine transport	1	1.102015e-4	1.000000e+0	1.000000e+0	9.074286e+3	1.102015e-4	1	1.102015e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SLC25A15
GO Biological Process	GO:0015822	ornithine transport	2	1.637095e-4	1.000000e+0	8.545636e-1	6.108382e+3	1.637095e-4	1	1.637095e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	8.680228e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	SLC25A15
GO Biological Process	GO:0000050	urea cycle	3	1.008500e-3	1.000000e+0	1.000000e+0	9.915719e+2	1.008500e-3	1	1.008500e-3	1.000000e+0	3	6.097223e-4	1.000000e+0	1.000000e+0	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	SLC25A15
GO Biological Process	GO:0019627	urea metabolic process	4	1.115049e-3	1.000000e+0	1.000000e+0	8.968217e+2	1.115049e-3	1	1.115049e-3	1.000000e+0	4	6.651516e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	12	1.000000e+0	8.333333e-2	unnamed	SLC25A15
GO Biological Process	GO:0071941	nitrogen cycle metabolic process	5	1.128862e-3	1.000000e+0	1.000000e+0	8.858480e+2	1.128862e-3	1	1.128862e-3	1.000000e+0	5	7.205809e-4	1.000000e+0	1.000000e+0	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	SLC25A15
GO Biological Process	GO:0043604	amide biosynthetic process	6	4.421251e-3	1.000000e+0	1.000000e+0	2.261803e+2	4.421251e-3	1	4.421251e-3	1.000000e+0	6	2.494318e-3	1.000000e+0	1.000000e+0	4.009111e+2	2.494318e-3	1	45	1.000000e+0	2.222222e-2	unnamed	SLC25A15
GO Biological Process	GO:0006839	mitochondrial transport	7	8.523746e-3	1.000000e+0	1.000000e+0	1.173193e+2	8.523746e-3	1	8.523746e-3	1.000000e+0	8	7.261238e-3	1.000000e+0	1.000000e+0	1.377176e+2	7.261238e-3	1	131	1.000000e+0	7.633588e-3	unnamed	SLC25A15
GO Biological Process	GO:0043603	cellular amide metabolic process	8	1.131490e-2	1.000000e+0	1.000000e+0	8.837903e+1	1.131490e-2	1	1.131490e-2	1.000000e+0	9	8.369824e-3	1.000000e+0	1.000000e+0	1.194768e+2	8.369824e-3	1	151	1.000000e+0	6.622517e-3	unnamed	SLC25A15
GO Biological Process	GO:0006865	amino acid transport	9	1.137929e-2	1.000000e+0	1.000000e+0	8.787896e+1	1.137929e-2	1	1.137929e-2	1.000000e+0	7	6.651516e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	120	1.000000e+0	8.333333e-3	unnamed	SLC25A15
GO Biological Process	GO:0046942	carboxylic acid transport	10	1.899186e-2	1.000000e+0	1.000000e+0	5.265415e+1	1.899186e-2	1	1.899186e-2	1.000000e+0	10	1.130758e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	204	1.000000e+0	4.901961e-3	unnamed	SLC25A15
GO Biological Process	GO:0015711	organic anion transport	11	2.827900e-2	1.000000e+0	1.000000e+0	3.536193e+1	2.827900e-2	1	2.827900e-2	1.000000e+0	11	1.673965e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	302	1.000000e+0	3.311258e-3	unnamed	SLC25A15
GO Biological Process	GO:0006520	cellular amino acid metabolic process	12	3.348268e-2	1.000000e+0	1.000000e+0	2.986619e+1	3.348268e-2	1	3.348268e-2	1.000000e+0	13	2.283687e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	412	1.000000e+0	2.427184e-3	unnamed	SLC25A15
GO Biological Process	GO:0006820	anion transport	13	3.528482e-2	1.000000e+0	1.000000e+0	2.834080e+1	3.528482e-2	1	3.528482e-2	1.000000e+0	12	2.183914e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	394	1.000000e+0	2.538071e-3	unnamed	SLC25A15
GO Biological Process	GO:0071705	nitrogen compound transport	14	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	14	2.361288e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	426	1.000000e+0	2.347418e-3	unnamed	SLC25A15
GO Biological Process	GO:1901566	organonitrogen compound biosynthetic process	15	5.924039e-2	1.000000e+0	1.000000e+0	1.688038e+1	5.924039e-2	1	5.924039e-2	1.000000e+0	15	3.104041e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	560	1.000000e+0	1.785714e-3	unnamed	SLC25A15
GO Biological Process	GO:0019752	carboxylic acid metabolic process	16	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	17	4.467602e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	806	1.000000e+0	1.240695e-3	unnamed	SLC25A15
GO Biological Process	GO:0006812	cation transport	17	7.387615e-2	1.000000e+0	1.000000e+0	1.353617e+1	7.387615e-2	1	7.387615e-2	1.000000e+0	16	3.807993e-2	1.000000e+0	1.000000e+0	2.626055e+1	3.807993e-2	1	687	1.000000e+0	1.455604e-3	unnamed	SLC25A15
GO Biological Process	GO:0043436	oxoacid metabolic process	18	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	18	5.088410e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	918	1.000000e+0	1.089325e-3	unnamed	SLC25A15
GO Biological Process	GO:0006082	organic acid metabolic process	19	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	19	5.177097e-2	1.000000e+0	1.000000e+0	1.931585e+1	5.177097e-2	1	934	1.000000e+0	1.070664e-3	unnamed	SLC25A15
GO Biological Process	GO:0046907	intracellular transport	20	8.800771e-2	1.000000e+0	1.000000e+0	1.136264e+1	8.800771e-2	1	8.800771e-2	1.000000e+0	21	6.086137e-2	1.000000e+0	1.000000e+0	1.643078e+1	6.086137e-2	1	1098	1.000000e+0	9.107468e-4	unnamed	SLC25A15
GO Biological Process	GO:0006811	ion transport	21	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	20	5.980821e-2	1.000000e+0	1.000000e+0	1.672011e+1	5.980821e-2	1	1079	1.000000e+0	9.267841e-4	unnamed	SLC25A15
GO Biological Process	GO:0051649	establishment of localization in cell	22	1.284678e-1	1.000000e+0	1.000000e+0	7.784051e+0	1.284678e-1	1	1.284678e-1	1.000000e+0	22	8.192451e-2	1.000000e+0	1.000000e+0	1.220636e+1	8.192451e-2	1	1478	1.000000e+0	6.765900e-4	unnamed	SLC25A15
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	23	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	23	8.552741e-2	1.000000e+0	1.000000e+0	1.169216e+1	8.552741e-2	1	1543	1.000000e+0	6.480881e-4	unnamed	SLC25A15
GO Biological Process	GO:0071702	organic substance transport	24	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	24	9.373095e-2	1.000000e+0	1.000000e+0	1.066884e+1	9.373095e-2	1	1691	1.000000e+0	5.913661e-4	unnamed	SLC25A15
GO Biological Process	GO:0051641	cellular localization	25	1.548748e-1	1.000000e+0	1.000000e+0	6.456828e+0	1.548748e-1	1	1.548748e-1	1.000000e+0	25	9.605898e-2	1.000000e+0	1.000000e+0	1.041027e+1	9.605898e-2	1	1733	1.000000e+0	5.770340e-4	unnamed	SLC25A15
GO Biological Process	GO:0044281	small molecule metabolic process	26	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	26	1.345269e-1	1.000000e+0	1.000000e+0	7.433457e+0	1.345269e-1	1	2427	1.000000e+0	4.120313e-4	unnamed	SLC25A15
GO Biological Process	GO:0044765	single-organism transport	27	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	27	1.444488e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	2606	1.000000e+0	3.837299e-4	unnamed	SLC25A15
GO Biological Process	GO:0044710	single-organism metabolic process	28	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	29	1.696691e-1	1.000000e+0	1.000000e+0	5.893826e+0	1.696691e-1	1	3061	1.000000e+0	3.266906e-4	unnamed	SLC25A15
GO Biological Process	GO:0044271	cellular nitrogen compound biosynthetic process	29	2.531794e-1	1.000000e+0	1.000000e+0	3.949768e+0	2.531794e-1	1	2.531794e-1	1.000000e+0	28	1.584169e-1	1.000000e+0	1.000000e+0	6.312456e+0	1.584169e-1	1	2858	1.000000e+0	3.498950e-4	unnamed	SLC25A15
GO Biological Process	GO:0006810	transport	30	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	30	1.809212e-1	1.000000e+0	1.000000e+0	5.527267e+0	1.809212e-1	1	3264	1.000000e+0	3.063725e-4	unnamed	SLC25A15
GO Biological Process	GO:0051234	establishment of localization	31	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	31	1.836927e-1	1.000000e+0	1.000000e+0	5.443874e+0	1.836927e-1	1	3314	1.000000e+0	3.017502e-4	unnamed	SLC25A15
GO Biological Process	GO:0044249	cellular biosynthetic process	32	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	33	2.280916e-1	1.000000e+0	1.000000e+0	4.384204e+0	2.280916e-1	1	4115	1.000000e+0	2.430134e-4	unnamed	SLC25A15
GO Biological Process	GO:1901576	organic substance biosynthetic process	33	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	34	2.330802e-1	1.000000e+0	1.000000e+0	4.290369e+0	2.330802e-1	1	4205	1.000000e+0	2.378121e-4	unnamed	SLC25A15
GO Biological Process	GO:0009058	biosynthetic process	34	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	35	2.370157e-1	1.000000e+0	1.000000e+0	4.219130e+0	2.370157e-1	1	4276	1.000000e+0	2.338634e-4	unnamed	SLC25A15
GO Biological Process	GO:0051179	localization	35	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	32	2.234909e-1	1.000000e+0	1.000000e+0	4.474454e+0	2.234909e-1	1	4032	1.000000e+0	2.480159e-4	unnamed	SLC25A15
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	36	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	36	2.694973e-1	1.000000e+0	1.000000e+0	3.710613e+0	2.694973e-1	1	4862	1.000000e+0	2.056767e-4	unnamed	SLC25A15
GO Biological Process	GO:0006807	nitrogen compound metabolic process	37	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	37	2.925004e-1	1.000000e+0	1.000000e+0	3.418799e+0	2.925004e-1	1	5277	1.000000e+0	1.895016e-4	unnamed	SLC25A15
GO Biological Process	GO:0044237	cellular metabolic process	38	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	38	4.564049e-1	1.000000e+0	1.000000e+0	2.191037e+0	4.564049e-1	1	8234	1.000000e+0	1.214477e-4	unnamed	SLC25A15
GO Biological Process	GO:0044238	primary metabolic process	39	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	39	4.608946e-1	1.000000e+0	1.000000e+0	2.169693e+0	4.608946e-1	1	8315	1.000000e+0	1.202646e-4	unnamed	SLC25A15
GO Biological Process	GO:0071704	organic substance metabolic process	40	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	40	4.745857e-1	1.000000e+0	1.000000e+0	2.107101e+0	4.745857e-1	1	8562	1.000000e+0	1.167951e-4	unnamed	SLC25A15
GO Biological Process	GO:0008152	metabolic process	41	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	41	5.097278e-1	1.000000e+0	1.000000e+0	1.961831e+0	5.097278e-1	1	9196	1.000000e+0	1.087429e-4	unnamed	SLC25A15
GO Biological Process	GO:0044763	single-organism cellular process	42	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	42	5.605011e-1	1.000000e+0	1.000000e+0	1.784118e+0	5.605011e-1	1	10112	1.000000e+0	9.889241e-5	unnamed	SLC25A15
GO Biological Process	GO:0044699	single-organism process	43	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	43	6.164847e-1	1.000000e+0	1.000000e+0	1.622100e+0	6.164847e-1	1	11122	1.000000e+0	8.991189e-5	unnamed	SLC25A15
GO Biological Process	GO:0009987	cellular process	44	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	44	7.487944e-1	1.000000e+0	1.000000e+0	1.335480e+0	7.487944e-1	1	13509	1.000000e+0	7.402472e-5	unnamed	SLC25A15
GO Cellular Component	GO:0005743	mitochondrial inner membrane	1	2.386818e-2	1.000000e+0	1.000000e+0	4.189679e+1	2.386818e-2	1	2.386818e-2	1.000000e+0	1	2.073056e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	374	1.000000e+0	2.673797e-3	unnamed	SLC25A15
GO Cellular Component	GO:0019866	organelle inner membrane	2	2.738529e-2	1.000000e+0	1.000000e+0	3.651595e+1	2.738529e-2	1	2.738529e-2	1.000000e+0	2	2.261515e-2	1.000000e+0	1.000000e+0	4.421814e+1	2.261515e-2	1	408	1.000000e+0	2.450980e-3	unnamed	SLC25A15
GO Cellular Component	GO:0031966	mitochondrial membrane	3	3.702819e-2	1.000000e+0	1.000000e+0	2.700645e+1	3.702819e-2	1	3.702819e-2	1.000000e+0	3	2.943296e-2	1.000000e+0	1.000000e+0	3.397552e+1	2.943296e-2	1	531	1.000000e+0	1.883239e-3	unnamed	SLC25A15
GO Cellular Component	GO:0005740	mitochondrial envelope	4	3.831325e-2	1.000000e+0	1.000000e+0	2.610063e+1	3.831325e-2	1	3.831325e-2	1.000000e+0	4	3.092955e-2	1.000000e+0	1.000000e+0	3.233154e+1	3.092955e-2	1	558	1.000000e+0	1.792115e-3	unnamed	SLC25A15
GO Cellular Component	GO:0044429	mitochondrial part	5	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	5	4.395543e-2	1.000000e+0	1.000000e+0	2.275032e+1	4.395543e-2	1	793	1.000000e+0	1.261034e-3	unnamed	SLC25A15
GO Cellular Component	GO:0031967	organelle envelope	6	6.812257e-2	1.000000e+0	1.000000e+0	1.467942e+1	6.812257e-2	1	6.812257e-2	1.000000e+0	6	4.794634e-2	1.000000e+0	1.000000e+0	2.085665e+1	4.794634e-2	1	865	1.000000e+0	1.156069e-3	unnamed	SLC25A15
GO Cellular Component	GO:0031975	envelope	7	6.827720e-2	1.000000e+0	1.000000e+0	1.464618e+1	6.827720e-2	1	6.827720e-2	1.000000e+0	7	4.816806e-2	1.000000e+0	1.000000e+0	2.076064e+1	4.816806e-2	1	869	1.000000e+0	1.150748e-3	unnamed	SLC25A15
GO Cellular Component	GO:0005739	mitochondrion	8	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	8	8.791087e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	1586	1.000000e+0	6.305170e-4	unnamed	SLC25A15
GO Cellular Component	GO:0031090	organelle membrane	9	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	9	1.426750e-1	1.000000e+0	1.000000e+0	7.008936e+0	1.426750e-1	1	2574	1.000000e+0	3.885004e-4	unnamed	SLC25A15
GO Cellular Component	GO:0016021	integral to membrane	10	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	10	2.916135e-1	1.000000e+0	1.000000e+0	3.429196e+0	2.916135e-1	1	5261	1.000000e+0	1.900779e-4	unnamed	SLC25A15
GO Cellular Component	GO:0031224	intrinsic to membrane	11	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	11	2.978771e-1	1.000000e+0	1.000000e+0	3.357090e+0	2.978771e-1	1	5374	1.000000e+0	1.860811e-4	unnamed	SLC25A15
GO Cellular Component	GO:0044446	intracellular organelle part	12	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	13	3.595144e-1	1.000000e+0	1.000000e+0	2.781529e+0	3.595144e-1	1	6486	1.000000e+0	1.541782e-4	unnamed	SLC25A15
GO Cellular Component	GO:0044422	organelle part	13	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	14	3.657225e-1	1.000000e+0	1.000000e+0	2.734313e+0	3.657225e-1	1	6598	1.000000e+0	1.515611e-4	unnamed	SLC25A15
GO Cellular Component	GO:0044444	cytoplasmic part	14	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	15	3.898343e-1	1.000000e+0	1.000000e+0	2.565193e+0	3.898343e-1	1	7033	1.000000e+0	1.421868e-4	unnamed	SLC25A15
GO Cellular Component	GO:0044425	membrane part	15	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	12	3.432737e-1	1.000000e+0	1.000000e+0	2.913128e+0	3.432737e-1	1	6193	1.000000e+0	1.614726e-4	unnamed	SLC25A15
GO Cellular Component	GO:0016020	membrane	16	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	16	4.353417e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	7854	1.000000e+0	1.273237e-4	unnamed	SLC25A15
GO Cellular Component	GO:0005737	cytoplasm	17	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	17	5.240840e-1	1.000000e+0	1.000000e+0	1.908091e+0	5.240840e-1	1	9455	1.000000e+0	1.057641e-4	unnamed	SLC25A15
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	18	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	18	5.549582e-1	1.000000e+0	1.000000e+0	1.801938e+0	5.549582e-1	1	10012	1.000000e+0	9.988014e-5	unnamed	SLC25A15
GO Cellular Component	GO:0043227	membrane-bounded organelle	19	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	19	5.568427e-1	1.000000e+0	1.000000e+0	1.795839e+0	5.568427e-1	1	10046	1.000000e+0	9.954211e-5	unnamed	SLC25A15
GO Cellular Component	GO:0043229	intracellular organelle	20	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	20	6.092789e-1	1.000000e+0	1.000000e+0	1.641285e+0	6.092789e-1	1	10992	1.000000e+0	9.097525e-5	unnamed	SLC25A15
GO Cellular Component	GO:0043226	organelle	21	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	21	6.110526e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	11024	1.000000e+0	9.071118e-5	unnamed	SLC25A15
GO Cellular Component	GO:0044424	intracellular part	22	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	22	6.971897e-1	1.000000e+0	1.000000e+0	1.434330e+0	6.971897e-1	1	12578	1.000000e+0	7.950390e-5	unnamed	SLC25A15
GO Cellular Component	GO:0005622	intracellular	23	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	23	7.066127e-1	1.000000e+0	1.000000e+0	1.415202e+0	7.066127e-1	1	12748	1.000000e+0	7.844368e-5	unnamed	SLC25A15
GO Cellular Component	GO:0044464	cell part	24	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	24	8.202982e-1	1.000000e+0	1.000000e+0	1.219069e+0	8.202982e-1	1	14799	1.000000e+0	6.757213e-5	unnamed	SLC25A15
GO Cellular Component	GO:0005623	cell	25	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	25	8.203536e-1	1.000000e+0	1.000000e+0	1.218986e+0	8.203536e-1	1	14800	1.000000e+0	6.756757e-5	unnamed	SLC25A15
Human Phenotype	HP:0200119	Acute hepatitis	1	8.462476e-5	5.201038e-1	5.201038e-1	1.181687e+4	8.462476e-5	1	8.462476e-5	1.000000e+0	1	5.542930e-5	3.406685e-1	3.406685e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	SLC25A15
Human Phenotype	HP:0012026	Hyperornithinemia	1	8.462476e-5	5.201038e-1	5.201038e-1	1.181687e+4	8.462476e-5	1	8.462476e-5	1.000000e+0	1	5.542930e-5	3.406685e-1	3.406685e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	SLC25A15
Human Phenotype	HP:0002572	Episodic vomiting	3	3.363983e-4	1.000000e+0	6.891680e-1	2.972667e+3	3.363983e-4	1	3.363983e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	4.542246e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	SLC25A15
Human Phenotype	HP:0002038	Protein avoidance	4	6.138017e-4	1.000000e+0	9.431063e-1	1.629191e+3	6.138017e-4	1	6.138017e-4	1.000000e+0	4	2.771465e-4	1.000000e+0	4.258356e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	SLC25A15
Human Phenotype	HP:0002313	Spastic paraparesis	5	1.179144e-3	1.000000e+0	1.000000e+0	8.480728e+2	1.179144e-3	1	1.179144e-3	1.000000e+0	5	6.097223e-4	1.000000e+0	7.494707e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	SLC25A15
Human Phenotype	HP:0002169	Clonus	6	1.313078e-3	1.000000e+0	1.000000e+0	7.615693e+2	1.313078e-3	1	1.313078e-3	1.000000e+0	11	1.385732e-3	1.000000e+0	7.742463e-1	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	SLC25A15
Human Phenotype	HP:0000533	Chorioretinal atrophy	7	1.539862e-3	1.000000e+0	1.000000e+0	6.494088e+2	1.539862e-3	1	1.539862e-3	1.000000e+0	5	6.097223e-4	1.000000e+0	7.494707e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	SLC25A15
Human Phenotype	HP:0006846	Acute encephalopathy	8	1.652567e-3	1.000000e+0	1.000000e+0	6.051193e+2	1.652567e-3	1	1.652567e-3	1.000000e+0	10	1.219445e-3	1.000000e+0	7.494709e-1	8.200455e+2	1.219445e-3	1	22	1.000000e+0	4.545455e-2	unnamed	SLC25A15
Human Phenotype	HP:0007894	Hypopigmentation of the fundus	9	1.867217e-3	1.000000e+0	1.000000e+0	5.355563e+2	1.867217e-3	1	1.867217e-3	1.000000e+0	9	1.164015e-3	1.000000e+0	7.948929e-1	8.590952e+2	1.164015e-3	1	21	1.000000e+0	4.761905e-2	unnamed	SLC25A15
Human Phenotype	HP:0002385	Paraparesis	10	2.290489e-3	1.000000e+0	1.000000e+0	4.365879e+2	2.290489e-3	1	2.290489e-3	1.000000e+0	8	1.108586e-3	1.000000e+0	8.516712e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	SLC25A15
Human Phenotype	HP:0002495	Impaired vibratory sensation	11	2.593184e-3	1.000000e+0	1.000000e+0	3.856263e+2	2.593184e-3	1	2.593184e-3	1.000000e+0	12	1.552020e-3	1.000000e+0	7.948929e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	SLC25A15
Human Phenotype	HP:0012115	Hepatitis	12	2.639051e-3	1.000000e+0	1.000000e+0	3.789242e+2	2.639051e-3	1	2.639051e-3	1.000000e+0	14	1.607450e-3	1.000000e+0	7.056706e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	SLC25A15
Human Phenotype	HP:0002370	Poor coordination	13	2.715859e-3	1.000000e+0	1.000000e+0	3.682076e+2	2.715859e-3	1	2.715859e-3	1.000000e+0	7	1.053157e-3	1.000000e+0	9.246718e-1	9.495263e+2	1.053157e-3	1	19	1.000000e+0	5.263158e-2	unnamed	SLC25A15
Human Phenotype	HP:0001987	Hyperammonemia	14	3.140843e-3	1.000000e+0	1.000000e+0	3.183858e+2	3.140843e-3	1	3.140843e-3	1.000000e+0	15	1.773738e-3	1.000000e+0	7.267596e-1	5.637812e+2	1.773738e-3	1	32	1.000000e+0	3.125000e-2	unnamed	SLC25A15
Human Phenotype	HP:0002157	Azotemia	15	3.661707e-3	1.000000e+0	1.000000e+0	2.730967e+2	3.661707e-3	1	3.661707e-3	1.000000e+0	16	2.217172e-3	1.000000e+0	8.516712e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	SLC25A15
Human Phenotype	HP:0004364	Abnormality of nitrogen compound homeostasis	16	3.705552e-3	1.000000e+0	1.000000e+0	2.698653e+2	3.705552e-3	1	3.705552e-3	1.000000e+0	17	2.272601e-3	1.000000e+0	8.216121e-1	4.400244e+2	2.272601e-3	1	41	1.000000e+0	2.439024e-2	unnamed	SLC25A15
Human Phenotype	HP:0002123	Generalized myoclonic seizures	17	3.707541e-3	1.000000e+0	1.000000e+0	2.697205e+2	3.707541e-3	1	3.707541e-3	1.000000e+0	12	1.552020e-3	1.000000e+0	7.948929e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	SLC25A15
Human Phenotype	HP:0002061	Lower limb spasticity	18	4.355900e-3	1.000000e+0	1.000000e+0	2.295737e+2	4.355900e-3	1	4.355900e-3	1.000000e+0	20	2.993182e-3	1.000000e+0	9.198048e-1	3.340926e+2	2.993182e-3	1	54	1.000000e+0	1.851852e-2	unnamed	SLC25A15
Human Phenotype	HP:0010551	Paraplegia/paraparesis	19	4.576718e-3	1.000000e+0	1.000000e+0	2.184972e+2	4.576718e-3	1	4.576718e-3	1.000000e+0	19	2.826894e-3	1.000000e+0	9.144258e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	SLC25A15
Human Phenotype	HP:0001259	Coma	20	5.560377e-3	1.000000e+0	1.000000e+0	1.798439e+2	5.560377e-3	1	5.560377e-3	1.000000e+0	22	3.270329e-3	1.000000e+0	9.136110e-1	3.057797e+2	3.270329e-3	1	59	1.000000e+0	1.694915e-2	unnamed	SLC25A15
Human Phenotype	HP:0000762	Decreased nerve conduction velocity	21	6.308917e-3	1.000000e+0	1.000000e+0	1.585058e+2	6.308917e-3	1	6.308917e-3	1.000000e+0	23	3.547475e-3	1.000000e+0	9.479470e-1	2.818906e+2	3.547475e-3	1	64	1.000000e+0	1.562500e-2	unnamed	SLC25A15
Human Phenotype	HP:0001298	Encephalopathy	22	6.546159e-3	1.000000e+0	1.000000e+0	1.527613e+2	6.546159e-3	1	6.546159e-3	1.000000e+0	25	3.824622e-3	1.000000e+0	9.402451e-1	2.614638e+2	3.824622e-3	1	69	1.000000e+0	1.449275e-2	unnamed	SLC25A15
Human Phenotype	HP:0003134	Abnormality of peripheral nerve conduction	23	6.625753e-3	1.000000e+0	1.000000e+0	1.509262e+2	6.625753e-3	1	6.625753e-3	1.000000e+0	24	3.658334e-3	1.000000e+0	9.368384e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	SLC25A15
Human Phenotype	HP:0001254	Lethargy	24	7.240727e-3	1.000000e+0	1.000000e+0	1.381077e+2	7.240727e-3	1	7.240727e-3	1.000000e+0	26	4.212627e-3	1.000000e+0	9.958002e-1	2.373816e+2	4.212627e-3	1	76	1.000000e+0	1.315789e-2	unnamed	SLC25A15
Human Phenotype	HP:0001328	Specific learning disability	25	7.343429e-3	1.000000e+0	1.000000e+0	1.361762e+2	7.343429e-3	1	7.343429e-3	1.000000e+0	18	2.438889e-3	1.000000e+0	8.327451e-1	4.100227e+2	2.438889e-3	1	44	1.000000e+0	2.272727e-2	unnamed	SLC25A15
Human Phenotype	HP:0002197	Generalized seizures	26	7.468870e-3	1.000000e+0	1.000000e+0	1.338891e+2	7.468870e-3	1	7.468870e-3	1.000000e+0	21	3.104041e-3	1.000000e+0	9.084493e-1	3.221607e+2	3.104041e-3	1	56	1.000000e+0	1.785714e-2	unnamed	SLC25A15
Human Phenotype	HP:0002013	Vomiting	27	8.572818e-3	1.000000e+0	1.000000e+0	1.166478e+2	8.572818e-3	1	8.572818e-3	1.000000e+0	29	5.875506e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	106	1.000000e+0	9.433962e-3	unnamed	SLC25A15
Human Phenotype	HP:0001410	Decreased liver function	28	1.036810e-2	1.000000e+0	1.000000e+0	9.644966e+1	1.036810e-2	1	1.036810e-2	1.000000e+0	33	7.205809e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	130	1.000000e+0	7.692308e-3	unnamed	SLC25A15
Human Phenotype	HP:0003474	Sensory impairment	29	1.045561e-2	1.000000e+0	1.000000e+0	9.564247e+1	1.045561e-2	1	1.045561e-2	1.000000e+0	28	5.653789e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	102	1.000000e+0	9.803922e-3	unnamed	SLC25A15
Human Phenotype	HP:0004372	Reduced consciousness/confusion	30	1.224302e-2	1.000000e+0	1.000000e+0	8.167919e+1	1.224302e-2	1	1.224302e-2	1.000000e+0	34	7.649243e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	138	1.000000e+0	7.246377e-3	unnamed	SLC25A15
Human Phenotype	HP:0000532	Chorioretinal abnormality	31	1.225933e-2	1.000000e+0	1.000000e+0	8.157055e+1	1.225933e-2	1	1.225933e-2	1.000000e+0	27	5.487501e-3	1.000000e+0	1.000000e+0	1.822323e+2	5.487501e-3	1	99	1.000000e+0	1.010101e-2	unnamed	SLC25A15
Human Phenotype	HP:0004337	Abnormality of amino acid metabolism	32	1.235776e-2	1.000000e+0	1.000000e+0	8.092080e+1	1.235776e-2	1	1.235776e-2	1.000000e+0	32	6.485228e-3	1.000000e+0	1.000000e+0	1.541966e+2	6.485228e-3	1	117	1.000000e+0	8.547009e-3	unnamed	SLC25A15
Human Phenotype	HP:0000610	Abnormality of the choroid	33	1.306834e-2	1.000000e+0	1.000000e+0	7.652083e+1	1.306834e-2	1	1.306834e-2	1.000000e+0	30	6.097223e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	110	1.000000e+0	9.090909e-3	unnamed	SLC25A15
Human Phenotype	HP:0004354	Abnormality of carboxylic acid metabolism	34	1.349326e-2	1.000000e+0	1.000000e+0	7.411106e+1	1.349326e-2	1	1.349326e-2	1.000000e+0	35	7.704673e-3	1.000000e+0	1.000000e+0	1.297914e+2	7.704673e-3	1	139	1.000000e+0	7.194245e-3	unnamed	SLC25A15
Human Phenotype	HP:0002120	Cerebral cortical atrophy	35	1.433858e-2	1.000000e+0	1.000000e+0	6.974193e+1	1.433858e-2	1	1.433858e-2	1.000000e+0	31	6.429799e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	116	1.000000e+0	8.620690e-3	unnamed	SLC25A15
Human Phenotype	HP:0002017	Nausea and vomiting	36	1.584584e-2	1.000000e+0	1.000000e+0	6.310803e+1	1.584584e-2	1	1.584584e-2	1.000000e+0	36	9.090405e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	164	1.000000e+0	6.097561e-3	unnamed	SLC25A15
Human Phenotype	HP:0001257	Spasticity	37	2.102269e-2	1.000000e+0	1.000000e+0	4.756765e+1	2.102269e-2	1	2.102269e-2	1.000000e+0	46	1.424533e-2	1.000000e+0	1.000000e+0	7.019844e+1	1.424533e-2	1	257	1.000000e+0	3.891051e-3	unnamed	SLC25A15
Human Phenotype	HP:0008051	Abnormality of the retinal pigment epithelium	38	2.142508e-2	1.000000e+0	1.000000e+0	4.667427e+1	2.142508e-2	1	2.142508e-2	1.000000e+0	41	1.202816e-2	1.000000e+0	1.000000e+0	8.313825e+1	1.202816e-2	1	217	1.000000e+0	4.608295e-3	unnamed	SLC25A15
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	39	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	37	1.069785e-2	1.000000e+0	1.000000e+0	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	SLC25A15
Human Phenotype	HP:0002240	Hepatomegaly	40	2.226096e-2	1.000000e+0	1.000000e+0	4.492169e+1	2.226096e-2	1	2.226096e-2	1.000000e+0	47	1.612993e-2	1.000000e+0	1.000000e+0	6.199656e+1	1.612993e-2	1	291	1.000000e+0	3.436426e-3	unnamed	SLC25A15
Human Phenotype	HP:0002059	Cerebral atrophy	41	2.274528e-2	1.000000e+0	1.000000e+0	4.396517e+1	2.274528e-2	1	2.274528e-2	1.000000e+0	38	1.114129e-2	1.000000e+0	1.000000e+0	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	SLC25A15
Human Phenotype	HP:0007369	Atrophy/Degeneration affecting the cerebrum	42	2.306765e-2	1.000000e+0	1.000000e+0	4.335075e+1	2.306765e-2	1	2.306765e-2	1.000000e+0	39	1.136301e-2	1.000000e+0	1.000000e+0	8.800488e+1	1.136301e-2	1	205	1.000000e+0	4.878049e-3	unnamed	SLC25A15
Human Phenotype	HP:0012444	Brain atrophy	43	2.343110e-2	1.000000e+0	1.000000e+0	4.267832e+1	2.343110e-2	1	2.343110e-2	1.000000e+0	40	1.164015e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	210	1.000000e+0	4.761905e-3	unnamed	SLC25A15
Human Phenotype	HP:0009830	Peripheral neuropathy	44	2.399642e-2	1.000000e+0	1.000000e+0	4.167288e+1	2.399642e-2	1	2.399642e-2	1.000000e+0	45	1.385732e-2	1.000000e+0	1.000000e+0	7.216400e+1	1.385732e-2	1	250	1.000000e+0	4.000000e-3	unnamed	SLC25A15
Human Phenotype	HP:0002311	Incoordination	45	2.557425e-2	1.000000e+0	1.000000e+0	3.910184e+1	2.557425e-2	1	2.557425e-2	1.000000e+0	42	1.208359e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	218	1.000000e+0	4.587156e-3	unnamed	SLC25A15
Human Phenotype	HP:0007367	Atrophy/Degeneration affecting the central nervous system	46	2.578991e-2	1.000000e+0	1.000000e+0	3.877485e+1	2.578991e-2	1	2.578991e-2	1.000000e+0	43	1.352475e-2	1.000000e+0	1.000000e+0	7.393852e+1	1.352475e-2	1	244	1.000000e+0	4.098361e-3	unnamed	SLC25A15
Human Phenotype	HP:0003271	Visceromegaly	47	2.717827e-2	1.000000e+0	1.000000e+0	3.679410e+1	2.717827e-2	1	2.717827e-2	1.000000e+0	51	1.989912e-2	1.000000e+0	1.000000e+0	5.025348e+1	1.989912e-2	1	359	1.000000e+0	2.785515e-3	unnamed	SLC25A15
Human Phenotype	HP:0001347	Hyperreflexia	48	2.789222e-2	1.000000e+0	1.000000e+0	3.585229e+1	2.789222e-2	1	2.789222e-2	1.000000e+0	50	1.729394e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	312	1.000000e+0	3.205128e-3	unnamed	SLC25A15
Human Phenotype	HP:0001508	Failure to thrive	49	2.902184e-2	1.000000e+0	1.000000e+0	3.445681e+1	2.902184e-2	1	2.902184e-2	1.000000e+0	49	1.685051e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	304	1.000000e+0	3.289474e-3	unnamed	SLC25A15
Human Phenotype	HP:0003812	Phenotypic variability	50	3.032972e-2	1.000000e+0	1.000000e+0	3.297096e+1	3.032972e-2	1	3.032972e-2	1.000000e+0	48	1.646250e-2	1.000000e+0	1.000000e+0	6.074411e+1	1.646250e-2	1	297	1.000000e+0	3.367003e-3	unnamed	SLC25A15
Human Phenotype	HP:0000553	Abnormality of the uvea	51	3.135455e-2	1.000000e+0	1.000000e+0	3.189329e+1	3.135455e-2	1	3.135455e-2	1.000000e+0	44	1.374647e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	248	1.000000e+0	4.032258e-3	unnamed	SLC25A15
Human Phenotype	HP:0001276	Hypertonia	52	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	52	2.089685e-2	1.000000e+0	1.000000e+0	4.785411e+1	2.089685e-2	1	377	1.000000e+0	2.652520e-3	unnamed	SLC25A15
Human Phenotype	HP:0011443	Abnormality of coordination	53	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	53	2.267058e-2	1.000000e+0	1.000000e+0	4.411002e+1	2.267058e-2	1	409	1.000000e+0	2.444988e-3	unnamed	SLC25A15
Human Phenotype	HP:0000479	Abnormality of the retina	54	4.191016e-2	1.000000e+0	1.000000e+0	2.386056e+1	4.191016e-2	1	4.191016e-2	1.000000e+0	54	2.444432e-2	1.000000e+0	1.000000e+0	4.090930e+1	2.444432e-2	1	441	1.000000e+0	2.267574e-3	unnamed	SLC25A15
Human Phenotype	HP:0001392	Abnormality of the liver	55	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	58	3.126213e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	564	1.000000e+0	1.773050e-3	unnamed	SLC25A15
Human Phenotype	HP:0004325	Decreased body weight	56	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	55	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	SLC25A15
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	57	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	56	2.632892e-2	1.000000e+0	1.000000e+0	3.798105e+1	2.632892e-2	1	475	1.000000e+0	2.105263e-3	unnamed	SLC25A15
Human Phenotype	HP:0011458	Abdominal symptom	58	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	57	3.048611e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	550	1.000000e+0	1.818182e-3	unnamed	SLC25A15
Human Phenotype	HP:0001263	Global developmental delay	59	5.775253e-2	1.000000e+0	1.000000e+0	1.731526e+1	5.775253e-2	1	5.775253e-2	1.000000e+0	59	3.248157e-2	1.000000e+0	1.000000e+0	3.078669e+1	3.248157e-2	1	586	1.000000e+0	1.706485e-3	unnamed	SLC25A15
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	60	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	60	3.286957e-2	1.000000e+0	1.000000e+0	3.042327e+1	3.286957e-2	1	593	1.000000e+0	1.686341e-3	unnamed	SLC25A15
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	61	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	61	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	SLC25A15
Human Phenotype	HP:0001098	Abnormality of the fundus	62	5.873513e-2	1.000000e+0	1.000000e+0	1.702559e+1	5.873513e-2	1	5.873513e-2	1.000000e+0	61	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	SLC25A15
Human Phenotype	HP:0004329	Abnormality of the posterior segment of the eye	63	5.909903e-2	1.000000e+0	1.000000e+0	1.692075e+1	5.909903e-2	1	5.909903e-2	1.000000e+0	63	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	SLC25A15
Human Phenotype	HP:0004323	Abnormality of body weight	64	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	63	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	SLC25A15
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	65	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	66	3.641705e-2	1.000000e+0	1.000000e+0	2.745967e+1	3.641705e-2	1	657	1.000000e+0	1.522070e-3	unnamed	SLC25A15
Human Phenotype	HP:0100022	Abnormality of movement	66	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	67	3.652791e-2	1.000000e+0	1.000000e+0	2.737633e+1	3.652791e-2	1	659	1.000000e+0	1.517451e-3	unnamed	SLC25A15
Human Phenotype	HP:0001249	Intellectual disability	67	7.044946e-2	1.000000e+0	1.000000e+0	1.419457e+1	7.044946e-2	1	7.044946e-2	1.000000e+0	65	3.331301e-2	1.000000e+0	1.000000e+0	3.001830e+1	3.331301e-2	1	601	1.000000e+0	1.663894e-3	unnamed	SLC25A15
Human Phenotype	HP:0002060	Abnormality of the cerebrum	68	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	68	4.018624e-2	1.000000e+0	1.000000e+0	2.488414e+1	4.018624e-2	1	725	1.000000e+0	1.379310e-3	unnamed	SLC25A15
Human Phenotype	HP:0100547	Abnormality of the forebrain	69	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	69	4.040796e-2	1.000000e+0	1.000000e+0	2.474760e+1	4.040796e-2	1	729	1.000000e+0	1.371742e-3	unnamed	SLC25A15
Human Phenotype	HP:0001250	Seizures	70	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	70	4.195998e-2	1.000000e+0	1.000000e+0	2.383223e+1	4.195998e-2	1	757	1.000000e+0	1.321004e-3	unnamed	SLC25A15
Human Phenotype	HP:0011442	Abnormality of central motor function	71	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	71	4.484230e-2	1.000000e+0	1.000000e+0	2.230037e+1	4.484230e-2	1	809	1.000000e+0	1.236094e-3	unnamed	SLC25A15
Human Phenotype	HP:0000004	Onset and clinical course	72	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	73	5.071781e-2	1.000000e+0	1.000000e+0	1.971694e+1	5.071781e-2	1	915	1.000000e+0	1.092896e-3	unnamed	SLC25A15
Human Phenotype	HP:0012443	Abnormality of the brain	73	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	72	5.044066e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	910	1.000000e+0	1.098901e-3	unnamed	SLC25A15
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	74	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	74	5.448700e-2	1.000000e+0	1.000000e+0	1.835300e+1	5.448700e-2	1	983	1.000000e+0	1.017294e-3	unnamed	SLC25A15
Human Phenotype	HP:0012374	Abnormality of the globe	75	1.087826e-1	1.000000e+0	1.000000e+0	9.192650e+0	1.087826e-1	1	1.087826e-1	1.000000e+0	75	5.875506e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	1060	1.000000e+0	9.433962e-4	unnamed	SLC25A15
Human Phenotype	HP:0012372	Abnormal eye morphology	76	1.118366e-1	1.000000e+0	1.000000e+0	8.941615e+0	1.118366e-1	1	1.118366e-1	1.000000e+0	77	6.058422e-2	1.000000e+0	1.000000e+0	1.650595e+1	6.058422e-2	1	1093	1.000000e+0	9.149131e-4	unnamed	SLC25A15
Human Phenotype	HP:0001507	Growth abnormality	77	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	76	5.980821e-2	1.000000e+0	1.000000e+0	1.672011e+1	5.980821e-2	1	1079	1.000000e+0	9.267841e-4	unnamed	SLC25A15
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	78	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	81	7.344382e-2	1.000000e+0	1.000000e+0	1.361585e+1	7.344382e-2	1	1325	1.000000e+0	7.547170e-4	unnamed	SLC25A15
Human Phenotype	HP:0001438	Abnormality of the abdomen	79	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	78	6.806718e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	1228	1.000000e+0	8.143322e-4	unnamed	SLC25A15
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	80	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	79	6.839976e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	1234	1.000000e+0	8.103728e-4	unnamed	SLC25A15
Human Phenotype	HP:0100543	Cognitive impairment	81	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	80	6.878776e-2	1.000000e+0	1.000000e+0	1.453747e+1	6.878776e-2	1	1241	1.000000e+0	8.058018e-4	unnamed	SLC25A15
Human Phenotype	HP:0000007	Autosomal recessive inheritance	82	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	84	8.924117e-2	1.000000e+0	1.000000e+0	1.120559e+1	8.924117e-2	1	1610	1.000000e+0	6.211180e-4	unnamed	SLC25A15
Human Phenotype	HP:0000478	Abnormality of the eye	83	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	82	7.715759e-2	1.000000e+0	1.000000e+0	1.296049e+1	7.715759e-2	1	1392	1.000000e+0	7.183908e-4	unnamed	SLC25A15
Human Phenotype	HP:0011446	Abnormality of higher mental function	84	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	83	7.843246e-2	1.000000e+0	1.000000e+0	1.274982e+1	7.843246e-2	1	1415	1.000000e+0	7.067138e-4	unnamed	SLC25A15
Human Phenotype	HP:0002011	Abnormality of the central nervous system	85	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	85	9.567097e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	1726	1.000000e+0	5.793743e-4	unnamed	SLC25A15
Human Phenotype	HP:0000707	Abnormality of the nervous system	86	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	86	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	SLC25A15
Human Phenotype	HP:0000005	Mode of inheritance	87	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	87	1.452248e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	2620	1.000000e+0	3.816794e-4	unnamed	SLC25A15
Human Phenotype	HP:0000118	Phenotypic abnormality	88	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	88	1.548140e-1	1.000000e+0	1.000000e+0	6.459363e+0	1.548140e-1	1	2793	1.000000e+0	3.580380e-4	unnamed	SLC25A15
Human Phenotype	HP:0000001	All	89	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	89	1.564215e-1	1.000000e+0	1.000000e+0	6.392984e+0	1.564215e-1	1	2822	1.000000e+0	3.543586e-4	unnamed	SLC25A15
Disease Ontology	DOID:225	syndrome	1	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	1	1.052048e-1	1.000000e+0	1.000000e+0	9.505269e+0	1.052048e-1	1	1898	1.000000e+0	5.268704e-4	unnamed	SLC25A15
Disease Ontology	DOID:4	disease	2	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	2	4.371155e-1	1.000000e+0	1.000000e+0	2.287725e+0	4.371155e-1	1	7886	1.000000e+0	1.268070e-4	unnamed	SLC25A15
MSigDB Pathway	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	Genes involved in Metabolism of amino acids and derivatives	1	1.638180e-2	1.000000e+0	1.000000e+0	6.104334e+1	1.638180e-2	1	1.638180e-2	1.000000e+0	1	1.097500e-2	1.000000e+0	1.000000e+0	9.111616e+1	1.097500e-2	1	198	1.000000e+0	5.050505e-3	unnamed	SLC25A15
MSigDB Perturbation	BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN	Down-regulated genes in hepatocellular  carcinoma (HCC) subclass G123, defined by unsupervised clustering.	1	5.172754e-3	1.000000e+0	1.000000e+0	1.933206e+2	5.172754e-3	1	5.172754e-3	1.000000e+0	1	2.826894e-3	1.000000e+0	1.000000e+0	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	SLC25A15
MSigDB Perturbation	WOO_LIVER_CANCER_RECURRENCE_DN	Genes negatively correlated with recurrence free survival in patients with hepatitis B-related (HBV) hepatocellular carcinoma (HCC).	2	5.961475e-3	1.000000e+0	1.000000e+0	1.677437e+2	5.961475e-3	1	5.961475e-3	1.000000e+0	4	4.489773e-3	1.000000e+0	1.000000e+0	2.227284e+2	4.489773e-3	1	81	1.000000e+0	1.234568e-2	unnamed	SLC25A15
MSigDB Perturbation	WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	Up-regulated genes characteristic for autonomous thyroid adenoma.	3	7.018161e-3	1.000000e+0	1.000000e+0	1.424875e+2	7.018161e-3	1	7.018161e-3	1.000000e+0	2	3.880051e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	70	1.000000e+0	1.428571e-2	unnamed	SLC25A15
MSigDB Perturbation	HUANG_DASATINIB_RESISTANCE_DN	Genes whose expression negatively correlated with resistance of breast cancer cell lines to dasatinib [PubChem=3062316].	4	8.448201e-3	1.000000e+0	1.000000e+0	1.183684e+2	8.448201e-3	1	8.448201e-3	1.000000e+0	2	3.880051e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	70	1.000000e+0	1.428571e-2	unnamed	SLC25A15
MSigDB Perturbation	ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	The 'Cervical Cancer Proliferation Cluster' (CCPC): genes whose expression in cervical carcinoma positively correlates with that of the HPV E6 and E7 oncogenes; they are also differentially expressed according to disease outcome.	5	1.069990e-2	1.000000e+0	1.000000e+0	9.345884e+1	1.069990e-2	1	1.069990e-2	1.000000e+0	6	7.760102e-3	1.000000e+0	1.000000e+0	1.288643e+2	7.760102e-3	1	140	1.000000e+0	7.142857e-3	unnamed	SLC25A15
MSigDB Perturbation	MARKEY_RB1_CHRONIC_LOF_UP	Genes up-regulated in MEF cells (embryonic fibroblasts) isolated from RB1 [GeneID=5925] knockout mice: chronic loss of function (LOF) of RB1.	6	1.343301e-2	1.000000e+0	1.000000e+0	7.444348e+1	1.343301e-2	1	1.343301e-2	1.000000e+0	5	6.263511e-3	1.000000e+0	1.000000e+0	1.596549e+2	6.263511e-3	1	113	1.000000e+0	8.849558e-3	unnamed	SLC25A15
MSigDB Perturbation	MANALO_HYPOXIA_DN	Genes down-regulated in response to both hypoxia and overexpression of an active form of HIF1A [GeneID=3091].	7	1.907423e-2	1.000000e+0	1.000000e+0	5.242677e+1	1.907423e-2	1	1.907423e-2	1.000000e+0	10	1.540935e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	SLC25A15
MSigDB Perturbation	ENK_UV_RESPONSE_EPIDERMIS_UP	Genes up-regulated in epidermis after to UVB irradiation.	8	2.224455e-2	1.000000e+0	1.000000e+0	4.495483e+1	2.224455e-2	1	2.224455e-2	1.000000e+0	11	1.685051e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	304	1.000000e+0	3.289474e-3	unnamed	SLC25A15
MSigDB Perturbation	ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	Genes down-regulated in normal tissue adjacent to liver tumor, compared to the normal liver samples.	9	2.469410e-2	1.000000e+0	1.000000e+0	4.049551e+1	2.469410e-2	1	2.469410e-2	1.000000e+0	12	2.023169e-2	1.000000e+0	1.000000e+0	4.942740e+1	2.023169e-2	1	365	1.000000e+0	2.739726e-3	unnamed	SLC25A15
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_DN	Genes down-regulated in hepatoblastoma samples compared to normal liver tissue.	10	2.733553e-2	1.000000e+0	1.000000e+0	3.658243e+1	2.733553e-2	1	2.733553e-2	1.000000e+0	8	1.424533e-2	1.000000e+0	1.000000e+0	7.019844e+1	1.424533e-2	1	257	1.000000e+0	3.891051e-3	unnamed	SLC25A15
MSigDB Perturbation	MOOTHA_HUMAN_MITODB_6_2002	Mitochondrial genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	11	3.082442e-2	1.000000e+0	1.000000e+0	3.244181e+1	3.082442e-2	1	3.082442e-2	1.000000e+0	13	2.383460e-2	1.000000e+0	1.000000e+0	4.195581e+1	2.383460e-2	1	430	1.000000e+0	2.325581e-3	unnamed	SLC25A15
MSigDB Perturbation	MOOTHA_MITOCHONDRIA	Mitochondrial genes	12	3.109557e-2	1.000000e+0	1.000000e+0	3.215893e+1	3.109557e-2	1	3.109557e-2	1.000000e+0	14	2.483233e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	448	1.000000e+0	2.232143e-3	unnamed	SLC25A15
MSigDB Perturbation	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	Genes down-regulated in multiple myeloma (MM) cell lines treated with both decitabine [PubChem=451668] TSA [PubChem=5562].	13	3.340567e-2	1.000000e+0	1.000000e+0	2.993504e+1	3.340567e-2	1	3.340567e-2	1.000000e+0	9	1.507677e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	272	1.000000e+0	3.676471e-3	unnamed	SLC25A15
MSigDB Perturbation	DELYS_THYROID_CANCER_DN	Genes down-regulated in papillary thyroid carcinoma (PTC) compared to normal tissue.	14	4.103729e-2	1.000000e+0	1.000000e+0	2.436808e+1	4.103729e-2	1	4.103729e-2	1.000000e+0	7	1.274874e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	230	1.000000e+0	4.347826e-3	unnamed	SLC25A15
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	Genes in the expression cluster 'Early Progenitors Shared': up-regulated in hematopoietic progenitors from adult bone marrow and from fetal liver.	15	4.893719e-2	1.000000e+0	1.000000e+0	2.043436e+1	4.893719e-2	1	4.893719e-2	1.000000e+0	17	2.821351e-2	1.000000e+0	1.000000e+0	3.544401e+1	2.821351e-2	1	509	1.000000e+0	1.964637e-3	unnamed	SLC25A15
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	Genes down-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	16	6.444202e-2	1.000000e+0	1.000000e+0	1.551783e+1	6.444202e-2	1	6.444202e-2	1.000000e+0	16	2.682778e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	484	1.000000e+0	2.066116e-3	unnamed	SLC25A15
MSigDB Perturbation	SENESE_HDAC3_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC3 [GeneID=8841] by RNAi.	17	6.886261e-2	1.000000e+0	1.000000e+0	1.452167e+1	6.886261e-2	1	6.886261e-2	1.000000e+0	15	2.638435e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	476	1.000000e+0	2.100840e-3	unnamed	SLC25A15
MSigDB Perturbation	MARSON_BOUND_BY_FOXP3_STIMULATED	Genes with promoters bound by FOXP3 [GeneID=50943] in hybridoma cells stimulated by PMA [PubChem=4792] and ionomycin [PubChem=3733].	18	7.982095e-2	1.000000e+0	1.000000e+0	1.252804e+1	7.982095e-2	1	7.982095e-2	1.000000e+0	18	5.476415e-2	1.000000e+0	1.000000e+0	1.826012e+1	5.476415e-2	1	988	1.000000e+0	1.012146e-3	unnamed	SLC25A15
MSigDB Perturbation	MARSON_BOUND_BY_FOXP3_UNSTIMULATED	Genes with promoters bound by FOXP3 [GeneID=50943] in unstimulated hybridoma cells.	19	9.379232e-2	1.000000e+0	1.000000e+0	1.066185e+1	9.379232e-2	1	9.379232e-2	1.000000e+0	19	6.623801e-2	1.000000e+0	1.000000e+0	1.509707e+1	6.623801e-2	1	1195	1.000000e+0	8.368201e-4	unnamed	SLC25A15
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	20	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	20	7.654786e-2	1.000000e+0	1.000000e+0	1.306372e+1	7.654786e-2	1	1381	1.000000e+0	7.241130e-4	unnamed	SLC25A15
MSigDB miRNA Motifs	GTCTTCC,MIR-7	Targets of MicroRNA GTCTTCC,MIR-7	1	2.140900e-2	1.000000e+0	1.000000e+0	4.670933e+1	2.140900e-2	1	2.140900e-2	1.000000e+0	1	9.145834e-3	1.000000e+0	1.000000e+0	1.093394e+2	9.145834e-3	1	165	1.000000e+0	6.060606e-3	unnamed	SLC25A15
MSigDB miRNA Motifs	CTCAGGG,MIR-125B,MIR-125A	Targets of MicroRNA CTCAGGG,MIR-125B,MIR-125A	2	2.882432e-2	1.000000e+0	1.000000e+0	3.469293e+1	2.882432e-2	1	2.882432e-2	1.000000e+0	2	1.718308e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	310	1.000000e+0	3.225806e-3	unnamed	SLC25A15
InterPro	IPR018108	Mitochondrial substrate/solute carrier	1	2.911806e-3	1.000000e+0	1.000000e+0	3.434295e+2	2.911806e-3	1	2.911806e-3	1.000000e+0	1	3.048611e-3	1.000000e+0	1.000000e+0	3.280182e+2	3.048611e-3	1	55	1.000000e+0	1.818182e-2	unnamed	SLC25A15
InterPro	IPR023395	Mitochondrial carrier domain	1	2.911806e-3	1.000000e+0	1.000000e+0	3.434295e+2	2.911806e-3	1	2.911806e-3	1.000000e+0	1	3.048611e-3	1.000000e+0	1.000000e+0	3.280182e+2	3.048611e-3	1	55	1.000000e+0	1.818182e-2	unnamed	SLC25A15
TreeFam	TF314880	SLC25A15, SLC25A2	1	1.102015e-4	8.954974e-1	8.954974e-1	9.074286e+3	1.102015e-4	1	1.102015e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	SLC25A15
HGNC Gene Families	SLC	SLC	1	3.126915e-2	1.000000e+0	1.000000e+0	3.198041e+1	3.126915e-2	1	3.126915e-2	1.000000e+0	1	2.056427e-2	1.000000e+0	1.000000e+0	4.862803e+1	2.056427e-2	1	371	1.000000e+0	2.695418e-3	unnamed	SLC25A15
Ensembl Genes	5342	SLC25A15	1	8.462476e-5	1.000000e+0	1.000000e+0	1.181687e+4	8.462476e-5	1	8.462476e-5	1.000000e+0	1	5.542930e-5	1.000000e+0	1.000000e+0	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	SLC25A15
MSigDB Oncogenic Signatures	MYC_UP.V1_UP	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing MYC [Gene ID=4609] gene.	1	1.182324e-2	1.000000e+0	1.000000e+0	8.457919e+1	1.182324e-2	1	1.182324e-2	1.000000e+0	1	9.201264e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	166	1.000000e+0	6.024096e-3	unnamed	SLC25A15
MSigDB Oncogenic Signatures	ATF2_UP.V1_DN	Genes down-regulated in myometrial cells over-expressing ATF2 [Gene ID=1386] gene.	2	2.462208e-2	1.000000e+0	1.000000e+0	4.061395e+1	2.462208e-2	1	2.462208e-2	1.000000e+0	2	1.003270e-2	1.000000e+0	9.380575e-1	9.967403e+1	1.003270e-2	1	181	1.000000e+0	5.524862e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 24 h.	1	1.018445e-2	1.000000e+0	1.000000e+0	9.818892e+1	1.018445e-2	1	1.018445e-2	1.000000e+0	11	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naive CD8 T cells versus effector CD8 IL2RA [GeneID=3559] high T cells at.	2	1.300812e-2	1.000000e+0	1.000000e+0	7.687506e+1	1.300812e-2	1	1.300812e-2	1.000000e+0	15	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 4 h.	3	1.349462e-2	1.000000e+0	1.000000e+0	7.410363e+1	1.349462e-2	1	1.349462e-2	1.000000e+0	6	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_8H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 8 h.	4	1.518399e-2	1.000000e+0	1.000000e+0	6.585883e+1	1.518399e-2	1	1.518399e-2	1.000000e+0	15	1.080871e-2	1.000000e+0	1.000000e+0	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN	Genes down-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the untreated cells at 6 h.	5	1.536942e-2	1.000000e+0	1.000000e+0	6.506426e+1	1.536942e-2	1	1.536942e-2	1.000000e+0	13	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_24H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	6	1.583601e-2	1.000000e+0	1.000000e+0	6.314724e+1	1.583601e-2	1	1.583601e-2	1.000000e+0	19	1.103043e-2	1.000000e+0	1.000000e+0	9.065829e+1	1.103043e-2	1	199	1.000000e+0	5.025126e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of macrophages versus central memory CD4 [GeneID=920] T cells.	7	1.590685e-2	1.000000e+0	1.000000e+0	6.286599e+1	1.590685e-2	1	1.590685e-2	1.000000e+0	5	1.014356e-2	1.000000e+0	1.000000e+0	9.858470e+1	1.014356e-2	1	183	1.000000e+0	5.464481e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP	Genes up-regulated in comparison of CD4- [GeneID=920] CD8- thymocytes versus CD4- [GeneID=920] CD8+ thymocytes.	8	1.635340e-2	1.000000e+0	1.000000e+0	6.114936e+1	1.635340e-2	1	1.635340e-2	1.000000e+0	13	1.075328e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17721_0.5H_VS_4H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 0.5 h versus those stimulated with CpG DNA (TLR9 agonist) at 4 h.	9	1.701615e-2	1.000000e+0	1.000000e+0	5.876771e+1	1.701615e-2	1	1.701615e-2	1.000000e+0	18	1.091957e-2	1.000000e+0	1.000000e+0	9.157868e+1	1.091957e-2	1	197	1.000000e+0	5.076142e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN	Genes down-regulated in comparison of macrophages treated with control (hIgG1) versus those treated with TNFRSF6B [GeneID=8771].	10	1.708048e-2	1.000000e+0	1.000000e+0	5.854636e+1	1.708048e-2	1	1.708048e-2	1.000000e+0	3	9.700127e-3	1.000000e+0	1.000000e+0	1.030914e+2	9.700127e-3	1	175	1.000000e+0	5.714286e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE3982_MAC_VS_BCELL_DN	Genes down-regulated in comparison of macrophages versus B cells.	11	1.747412e-2	1.000000e+0	1.000000e+0	5.722747e+1	1.747412e-2	1	1.747412e-2	1.000000e+0	4	1.008813e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	182	1.000000e+0	5.494505e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of naive versus memory CD8 T cells (day 40+ after LCMV-Armstrong infection).	12	1.782268e-2	1.000000e+0	1.000000e+0	5.610827e+1	1.782268e-2	1	1.782268e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE12366_NAIVE_VS_MEMORY_BCELL_UP	Genes up-regulated in comparison of naive B cells versus memory B cells.	13	1.870236e-2	1.000000e+0	1.000000e+0	5.346919e+1	1.870236e-2	1	1.870236e-2	1.000000e+0	1	9.034976e-3	1.000000e+0	1.000000e+0	1.106810e+2	9.034976e-3	1	163	1.000000e+0	6.134969e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP	Genes up-regulated in comparison of activated CD8 T cells from ELF4 [GeneID=2000] defficient mice versus those from wild type animals.	14	1.895582e-2	1.000000e+0	1.000000e+0	5.275425e+1	1.895582e-2	1	1.895582e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE12366_GC_VS_NAIVE_BCELL_UP	Genes up-regulated in comparison of germinal center B cells versus naive B cells.	15	1.903828e-2	1.000000e+0	1.000000e+0	5.252575e+1	1.903828e-2	1	1.903828e-2	1.000000e+0	11	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE3982_MAC_VS_NKCELL_DN	Genes down-regulated in comparison of macrophages versus NK cells.	16	1.930850e-2	1.000000e+0	1.000000e+0	5.179067e+1	1.930850e-2	1	1.930850e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17721_CTRL_VS_CPG_0.5H_BMDM_UP	Genes up-regulated in comparison of control dendritic cells (DC) at 0 h versus those stimulated with CpG DNA (TLR9 agonist) at 0.5 h.	17	2.016185e-2	1.000000e+0	1.000000e+0	4.959863e+1	2.016185e-2	1	2.016185e-2	1.000000e+0	7	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_BCELL_UP	Genes up-regulated in comparison of mast cells versus B cells.	18	2.274394e-2	1.000000e+0	1.000000e+0	4.396776e+1	2.274394e-2	1	2.274394e-2	1.000000e+0	17	1.086414e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	SLC25A15
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 48 h versus the untreated cells at 48 h.	19	2.299035e-2	1.000000e+0	1.000000e+0	4.349651e+1	2.299035e-2	1	2.299035e-2	1.000000e+0	2	9.422981e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	170	1.000000e+0	5.882353e-3	unnamed	SLC25A15
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
